Now if they can only find a way to reverse or stop the progression. The ampakines medication that was set to be approved was denied this past summer, pending further studies and issues with dosage. Cortex (the manufacturer) took a big stock hit on that FDA ruling as well, so who knows where that will go. It looked so promising.

P.S. Hope your mom is doing well!